Follow-up Sinks Candesartan as Cardioprotection in Breast Cancer Follow-up Sinks Candesartan as Cardioprotection in Breast Cancer
The new PRADA findings suggest cardioprotective drugs may not be necessary for all patients during adjuvant breast cancer therapy, the authors say.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Cardiology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Heart | Hematology